Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseThe New England journal of medicine, 2022-11, Vol.387 (20), p.1855-1864 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2211023 ;PMID: 36342163Full text available |
|
2 |
Material Type: Article
|
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trialThe Lancet (British edition), 2015-06, Vol.385 (9984), p.2288-2295 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61943-7 ;PMID: 25769361 ;CODEN: LANCAOFull text available |
|
3 |
Material Type: Article
|
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLECirculation (New York, N.Y.), 2023-04, Vol.147 (16), p.1192-1203 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.122.063399 ;PMID: 36779348Full text available |
|
4 |
Material Type: Article
|
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialJournal of the American College of Cardiology, 2016-03, Vol.67 (10), p.1145-1154 [Peer Reviewed Journal]American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 15, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.12.062 ;PMID: 26965534Full text available |
|
5 |
Material Type: Article
|
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 TrialJournal of the American Heart Association, 2021-09, Vol.10 (17), p.e020446-e020446 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.120.020446 ;PMID: 34423649Full text available |
|
6 |
Material Type: Article
|
The StrongWomen-Healthy Hearts Program: Reducing Cardiovascular Disease Risk Factors in Rural Sedentary, Overweight, and Obese Midlife and Older WomenAmerican journal of public health (1971), 2009-07, Vol.99 (7), p.1271-1277 [Peer Reviewed Journal]2009 INIST-CNRS ;Copyright American Public Health Association Jul 2009 ;American Public Health Association 2009 ;ISSN: 0090-0036 ;EISSN: 1541-0048 ;DOI: 10.2105/AJPH.2008.145581 ;PMID: 19443826 ;CODEN: AJPEAGFull text available |
|
7 |
Material Type: Article
|
Changes in physical activity after building a greenway in a disadvantaged urban community: A natural experimentPreventive medicine reports, 2019-09, Vol.15, p.100941-100941, Article 100941 [Peer Reviewed Journal]The Authors ;2019 The Authors ;2019 The Authors 2019 ;ISSN: 2211-3355 ;EISSN: 2211-3355 ;DOI: 10.1016/j.pmedr.2019.100941 ;PMID: 31338283Full text available |
|
8 |
Material Type: Article
|
Changes in diet and physical activity resulting from the Shape Up Somerville community interventionBMC pediatrics, 2013-10, Vol.13 (1), p.157-157, Article 157 [Peer Reviewed Journal]COPYRIGHT 2013 BioMed Central Ltd. ;COPYRIGHT 2013 BioMed Central Ltd. ;2013 Folta et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Folta et al.; licensee BioMed Central Ltd. 2013 Folta et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2431 ;EISSN: 1471-2431 ;DOI: 10.1186/1471-2431-13-157 ;PMID: 24093936Full text available |
|
9 |
Material Type: Article
|
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialCirculation (New York, N.Y.), 2016-07, Vol.134 (1), p.24-36 [Peer Reviewed Journal]2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022361 ;PMID: 27358434Full text available |
|
10 |
Material Type: Article
|
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular DiseaseCirculation (New York, N.Y.), 2022-10, Vol.146 (15), p.1109-1119 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.061620 ;PMID: 36031810Full text available |
|
11 |
Material Type: Article
|
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 TrialCirculation (New York, N.Y.), 2020-04, Vol.141 (15), p.1227-1234 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044183 ;PMID: 31983236Full text available |
|
12 |
Material Type: Article
|
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIERCirculation (New York, N.Y.), 2018-08, Vol.138 (8), p.756-766 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034309 ;PMID: 29626068Full text available |
|
13 |
Material Type: Article
|
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trialEuropean heart journal, 2019-05, Vol.40 (19), p.1541-1550 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy861 ;PMID: 30624719Full text available |
|
14 |
Material Type: Article
|
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70Circulation (New York, N.Y.), 2022-05, Vol.145 (18), p.1377-1386 [Peer Reviewed Journal]2022 The Authors. 2022 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.059266 ;PMID: 35369705Full text available |
|
15 |
Material Type: Article
|
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 TrialCirculation (New York, N.Y.), 2019-11, Vol.140 (22), p.1792-1801 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.041346Full text available |
|
16 |
Material Type: Article
|
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery DiseaseArteriosclerosis, thrombosis, and vascular biology, 2021-12, Vol.41 (12), p.3005-3014 [Peer Reviewed Journal]ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.120.315757 ;PMID: 34706556Full text available |
|
17 |
Material Type: Article
|
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialJournal of the American College of Cardiology, 2022-08, Vol.80 (9), p.887-897 [Peer Reviewed Journal]ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.05.051Full text available |
|
18 |
Material Type: Article
|
Decision-Making During Percutaneous Coronary Intervention Guided by Optical Coherence Tomography: Insights From the LightLab InitiativeCirculation. Cardiovascular interventions, 2022-11, Vol.15 (11), p.872-881 [Peer Reviewed Journal]2022 The Authors. 2022 ;ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.122.011851 ;PMID: 36378739Full text available |
|
19 |
Material Type: Article
|
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionCirculation. Cardiovascular interventions, 2022-03, Vol.15 (3), p.e011382-e011382 [Peer Reviewed Journal]ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.121.011382 ;PMID: 35209731Full text available |
|
20 |
Material Type: Article
|
Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitorsClinical cardiology (Mahwah, N.J.), 2022-07, Vol.45 (7), p.794-801 [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals, LLC. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0160-9289 ;EISSN: 1932-8737 ;DOI: 10.1002/clc.23844 ;PMID: 35715946Full text available |